1. Costentin, C . Hepatocellular carcinoma surveillance. Presse Med. 2017;46(4):381-385.
Google Scholar | Crossref | Medline2. Clark, T, Maximin, S, Meier, J, et al. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol. 2015;44(6):479-486.
Google Scholar | Crossref | Medline3. Wallace, MC, Preen, D, Jeffrey, GP, et al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015;9(6):765-779.
Google Scholar | Crossref | Medline4. Hartke, J, Johnson, M, Ghabril, M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153-159.
Google Scholar | Crossref | Medline5. Vogel, A, Cervantes, A, Chau, I, et al. Hepatocellular carcinoma: eSMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):871-873.
Google Scholar | Crossref6. European Association for the Study of the Liver . Electronic address: [email protected]; european association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236.
Google Scholar | Crossref | Medline7. Villanueva, A . Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450-1462.
Google Scholar | Crossref | Medline8. Forner, A, Reig, M, Bruix, J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301-1314.
Google Scholar | Crossref | Medline9. Huang, L, Zhou, K, Zhang, K, et al. Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheterarterial chemoembolization. Int J Hyperthermia. 2019;36(1):1-9.
Google Scholar | Crossref10. Bannangkoon, K, Hongsakul, K, Tubtawee, T, et al. Rate and predictive factors for sustained complete response after selective transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma. Asian Pac J Cancer Prev. 2018;19(12):3545-3550.
Google Scholar | Crossref | Medline11. Wang, H, Du, PC, Wu, PC, et al. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the barcelona clinic liver cancer early stage and microvascular invasion. Hepatobiliary Surg Nutr. 2018;7(6):418-428.
Google Scholar | Crossref | Medline12. Sun, M, Shang, P, Bai, J, Li, S, Li, M. High-intensity focused ultrasound ablation combined with transcatheter arterial chemoembolization improves long-term efficacy and prognosis of primary liver cancer. J Clin Lab Anal. 2021;35(2):e23633.
Google Scholar | Crossref | Medline13. Zhang, Q, Bian, SQ, Lv, W, et al. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer. Eur Rev Med Pharmacol Sci. 2019;23(3):239-246.
Google Scholar | Medline14. Suh, SY, Leblanc, TW, Shelby, RA. Longitudinal patient-reported performance status assessment in the cancer clinic Is feasible and prognostic. J Oncol Pract. 2011;7(6):374-381.
Google Scholar | Crossref | Medline15. Cassinotto, C, Aubee, C, Doha, A. Diagnosis of hepatocellular carcinoma: an update on international guidelines. Diagn Interv Imaging. 2017;98(5):379-391.
Google Scholar | Crossref | Medline16. Péus, D, Newcomb, N, Hofer, S. Appraisal of the karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak. 2013;13:72.
Google Scholar | Crossref | Medline | ISI17. Liu, H, Wang, ZG, Fu, SY, et al. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partialhepatectomy for hepatocellular carcinoma within the milan criteria. Br J Surg. 2016;103(4):348-356.
Google Scholar | Crossref | Medline18. Thandassery, RB, Goenka, U, Goenka, MK. Role of local ablative therapy for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(3):S104-S111.
Google Scholar | Crossref | Medline19. Zhu, GQ, Sun, M, Liao, WT, et al. Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(9):935-945.
Google Scholar | Crossref | Medline20. Facciorusso, A, Serviddio, G, Muscatiello, N. Local ablative treatments for hepatocellular carcinoma: an updated review. World J Gastrointest Pharmacol Ther. 2016;7(4):477-489.
Google Scholar | Crossref | Medline21. Gu, L, Liu, H, Fan, H, et al. Treatment outcomes of transcatheter arterial chemoembolization combined with local ablativetherapy versus monotherapy in hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(2):199-210.
Google Scholar | Crossref | Medline22. Katsanos, K, Kitrou, P, Spiliopoulos, S, et al. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: a network meta-analysis of randomized controlled trials. PLoS One. 2017;12(9):e0184597.
Google Scholar | Crossref | Medline23. Li, C, Zhang, W, Zhang, R, et al. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Eur J Cancer. 2010;46(13):2513-2521.
Google Scholar | Crossref | Medline24. Li, CX, Wu, PH, Fan, WJ, et al. Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 2009;89(11):754-757.
Google Scholar | Medline25. Kim, J, Chung, DJ, Jung, SE, et al. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma<5cm: comparison with transarterial chemoembolisation monotherapy-preliminary observations. Br J Radiol. 2012;85 (1018): e940-e946.
Google Scholar | Crossref | Medline26. Zhao, J, Zhang, H, Wei, L, et al. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget. 2017;8(9):15101-15113.
Google Scholar | Crossref | Medline27. Luo, Y, Jiang, Y. Comparison of efficiency of TACE plus HIFU and TACE alone on patients with primary liver cancer. J Coll Physicians Surg Pak. 2019;29(5):414-417.
Google Scholar | Crossref | Medline28. Han, Y, Hou, GY, Wang, S, et al. High intensity focused ultrasound (HIFU) focal spot localization using harmonic motion imaging (HMI). Phys Med Biol. 2015;60(15):5911-5924.
Google Scholar | Crossref | Medline29. Ke, S, Ding, XM, Qian, XJ, et al. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justifed? World J Gastroenterol. 2013;19(42):7389-7398.
Google Scholar | Crossref | Medline30. Yamashita, S, Aoki, T, Inoue, Y, et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery. 2015;157(3):463-472.
Google Scholar | Crossref | Medline31. Ayuso, C, Rimola, J, Vilana, R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72-81.
Google Scholar | Crossref | Medline